Case Name: Katie KANE; Darla Booth; Arianna Rosales, individually and on behalf of all others similarly situated, Plaintiffs-Appellants, v. CHOBANI, LLC, Defendant-Appellee
Court: United States Court of Appeals for the Ninth Circuit
Jurisdiction: United States
Decision Date: 2016-03-24
Citations: 645 F. App'x 593
Docket Number: No. 14-15670
Parties: Katie KANE; Darla Booth; Arianna Rosales, individually and on behalf of all others similarly situated, Plaintiffs-Appellants, v. CHOBANI, LLC, Defendant-Appellee.
Judges: Before: McKEOWN, WARDLAW, and TALLMAN, Circuit Judges.
Reporter: West's Federal Appendix
Volume: 645
Pages: 593–595

Head Matter:
Katie KANE; Darla Booth; Arianna Rosales, individually and on behalf of all others similarly situated, Plaintiffs-Appellants, v. CHOBANI, LLC, Defendant-Appellee.
No. 14-15670.
United States Court of Appeals, Ninth Circuit.
Argued and Submitted March 16, 2016.
Filed March 24, 2016.
Darren Lee Brown, Provost Umphrey Law Firm, Beaumont, TX, Ben (Pierce) F. Gore, Pratt & Associates, San Jose, CA, Don Barrett, Don Barrett, P.A., Lexington, MS, Colin H. Dunn, Esquire, Clifford Law Offices, P.C., Chicago, IL, Patricia N. Syverson, Esquire, Bonnett Fairbourn Friedman & Balint PC, San Diego, CA, for Plaintiffs-Appellants.
Dale Joseph Giali, Andrew Edelstein, Mayer Brown LLP, Los Angeles, CA, Michael B. Kimberly, Andrew John Pincus, Mayer Brown LLP, Washington, DC, for Defendant-Appellee.
Before: McKEOWN, WARDLAW, and TALLMAN, Circuit Judges.

Opinion:
MEMORANDUM
Katie Kune, Arianna Rosales, and Darla Booth appeal the Rule 12(b)(6) dismissal of their putative class action asserting claims against Chobani, Inc. in connection with Chobani's labeling and sale of yogurt. We have jurisdiction under 28 U.S.C. § 1291. Wé vacate the district court's February 20, 2014 order granting Chobani's motion to dismiss the third amended complaint. We remand for entry of an order staying proceedings until such time as the U.S. Food and Drug Administration (FDA) completes' its proceedings regarding the use of the terms "evaporated cane juice" and "natural" in food labeling.
We remand this action to the district court with instructions to enter a stay of proceedings under the primary jurisdiction doctrine. Plaintiffs' claims arise from their assertions that Chobani deceptively and unlawfully labels its yogurt as "natural" in violation of FDA regulations, and that Chobani deceptively and unlawfully uses the term "evaporated cane juice" to describe its yogurt's added sugar ingredient. The delineation of the scope and permissible usage of the terms "natural" and "evaporated cane juice" in connection with food products "'implicates technical and policy questions that should be addressed in the first instance by the agency with regulatory authority over the relevant industry rather than by the judicial branch.' " Astiana v. Hain Celestial Grp., Inc., 783 F.3d 753, 760 (9th Cir.2015) (quoting Clark v. Time Warner Cable, 523 F.3d 1110, 1114 (9th Cir.2008)); see also 21 C.F.R. § 101.1 et seq., 131.200(d)(2), 168.110, 168.130.
Although "[cjommon sense tells us that . a court should not invoke primary jurisdiction when the agency is aware of but has expressed no interest in the subject matter of the litigation," Astiana, 783 F.3d at 761, this is not such a case. In November 2015, the FDA issued a request for comments regarding the use of the term "natural" in connection with food product labeling. See Use of the Term "Natural" in the Labeling of Human Food Products; Request for Information and Comments, 80 Fed.Reg. 69,905 (Nov. 12, 2015). And, in July 2015, the FDA represented that it expects to issue final guidance on the term "evaporated cane juice" by the end of 2016. Letter from Leslie Kux, Assoc. Comm'r for Policy, FDA, to Judge Edward Chen, U.S. Dist. Court for the N. Dist. of Cal. (July 8, 2015); see also Draft Guidance for Industry on Ingredients Declared as Evaporated Cane Juice; Reopening of Comment Period; Request for Comments, Data, and Information, 79 Fed.Reg. 12,507 (Mar. 5,2014).
Given the ongoing FDA proceedings regarding the terms "natural" and "evaporated cane juice," we conclude that resolution of this action will not be needlessly delayed and that judicial resources will be conserved by staying these proceedings. See Astiana, 783 F.3d at 760 ("[Ejfficiency is the deciding factor in whether to invoke primary jurisdiction.") (citation omitted).
We VACATE and REMAND with instructions that the district court stay this action pending resolution of the FDA's "natural" and "evaporated cane juice" proceedings.
Each party shall bear its own costs on appeal.
This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
. We note that the duration of the stay remains within the sound discretion of the district court. If future events render the FDA's apparently imminent resolution of the "evaporated cane juice" and "natural" issues illusory, such events should inform the district court's exercise of its discretion. See Astiana, 783 F.3d at 762.